|Quantity Discounts||1 - 9999|
|1 - 9999|
|1 - 9999|
Do you know what PMDA investigators look for first? Or how the process differs from the FDA’s? Do you need your own translator?
Knowing the answers to these and many more questions may mean the difference between getting a piece of a $20 billion (and growing) market or being shut out.
Read on …
In this 90-minute Encore presentation, device industry consultant David Dills — fresh from helping a client successfully pass a PMDA inspection — will give you the nuts and bolts of getting through this complex and difficult procedures. From the necessary preparation process to special considerations in managing the inspection, you’ll get step-by-step direction from someone who’s been there and back!
In addition, David will go over Japan’s regulatory system, what documents and systems the PMDA looks for and why devicemakers should use the Summary Technical Document format for their regulatory submissions.
Sign up your entire team to listen in and discover:
Don’t risk getting shut out of this lucrative market. Register now and you'll get an opportunity to ask your toughest questions during the Q&A session.
David Dills provides independent consultative services in various capacities from premarketing to postmarketing within the technical, quality, regulatory affairs and compliance arenas to pharmaceutical, Class I/II/III medical devices, in vitro diagnostics and biologics/biotech companies with an emphasis on establishing sustainable compliance systems. David has served as director of publications, Regulatory & Compliance, for the Institute of Validation Technology. Through his work, David has been affiliated with the life sciences industry for more than 19 years with increasing responsibilities in QA, quality engineering, validation, RA/compliance and corporate/operations management. He was previously employed on behalf of globally recognized device manufacturers and service providers in conjunction with marketing and business development responsibilities.
David’s areas of interest and expertise include executing process validation, supplier qualification, training, internal/due diligence audits, policy/procedure development, PM, risk management/assessment, ISO 9001/13485/14971, MDD 93/42/EEC, CE Marking, remediation, GxPs, SW validation/IT network, MDR/AE/product complaints, design/change control, CAPA, PMA, IDE, 510(k), NDA and e-CTD/CMCs submissions, interfacing with international regulatory bodies, QSIT and PAI inspections, sample accountability, and other related functions and tasks. David’s academic degrees include Environmental Science and Biology. He currently serves as advisor for the ASQ’s Section 1506 and as a former chair and co-chair. He is an active member of the Biomedical Division, RAPS, PDA, ISPE and other industry working groups.
|Date:||June 1–19, 2009|
|Location:||Your office or conference room (no need to travel!)|
Gather your team for maximum benefit! Your investment is for one dial-in.
We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.
Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600
Registrations may not be cancelled. Please contact customer service to make any substitutions.
Interested in Becoming a Speaker?
We're always looking for industry leaders eager to share their expertise at an FDAnews audioconference, webinar or physical conference. Our seasoned speaker community includes executives in the pharmaceutical, medical device and clinical trial industries, regulatory affairs, quality control, compliance, healthcare and academia, as well as several former — and current — top FDA officials. Click here to complete our speaker opportunity form and have a representative contact you about future opportunities.
Copyright ©2018. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing